A B S T R A C T Previouis tracer studies have suggested that 5'-monodeiodination of L-thyroxine (T4) in anterior pituitary may contriblute a substantial portion of specifically bound nuclear 3,5,3' L-triiodothyronine (T3) [1251]T3 ratio. In 10 hypothyroid rats given a single bolus of 400 ng T3/100 g body wt., the nuclear T3 by radioimmutnoassay was 1.0 + 0.06 pg/,ug DNA, whereas that expected from the T3 specific activity calculations was 0.85 pg/,ug DNA (P < 0.025). Serum T4 concentrations in these rats were < 0.25 ,ug/dl but the nuclear T3 derived from as little as 0.2 ,g/dl T4 could explain a large portion of these small discrepancies between observed and measured nuclear T3. In 29 normal rats, anterior pituitary nuclear T3 was 0.63+0.04 pg/,ug DNA, whereas that expected from the serum T3 concentration (55±2 ng/dl) was 0.23±0.02 pg/,ug DNA (P < 0.001). Total pituitary T3 based on this measurement was 92+6 pg. Because the maxiimal nuclear binding capacity for T3 in rat anterior pituitary is 0.77 pg/,ug DNA, these results suggest there is 82% occupancy of these nuclear receptors. The requirement for normal serum concentrations of both T4 and T3 to achieve normal nuclear T3 saturation in anterior Dr. Bavli was the recipient of
A B S T R A C T Previouis tracer studies have suggested that 5'-monodeiodination of L-thyroxine (T4) in anterior pituitary may contriblute a substantial portion of specifically bound nuclear 3,5,3' L-triiodothyronine (T3) in this tissue in rats. To evaluate this possibility, a radioimmunoassay for nuclear T3 in individual anterior pituitaries was developed. Animals received [1251]_ T3 60 min before removal of the anterior pituitary and isolation of the nuclei by differential centrifugation. This allowed calculation of the nuclear:serum T3 ratio and comparison of expected with imeasured T3. T3 was extracted in ethanol, dried, and reconstituted in assay buffer. In untreated hypothyroid rats, anterior pituitary nuclear T3 was 0.18 + 0.06 pg/,ug DNA which was 0.13 pg/,ug DNA greater than expected from the serum T3 concentration and the pituitary nuclear: serum
[1251]T3 ratio. In 10 hypothyroid rats given a single bolus of 400 ng T3/100 g body wt., the nuclear T3 by radioimmutnoassay was 1.0 + 0.06 pg/,ug DNA, whereas that expected from the T3 specific activity calculations was 0.85 pg/,ug DNA (P < 0.025). Serum T4 concentrations in these rats were < 0.25 ,ug/dl but the nuclear T3 derived from as little as 0.2 ,g/dl T4 could explain a large portion of these small discrepancies between observed and measured nuclear T3. In 29 normal rats, INTRODUCTION Recent in vivo and in vitro stuidies in hypothyroid rats have demonstrated that there is rapid intrapituitary monodeiodination of L-thyroxine (T4)' to 3,5,3' Ltriiodothyronine (T3) and that this conversion is required for the rapid inhibition of thyroid-stimulating hormone (TSH) release found after infuision of physiological quantities of T4 (1) (2) (3) (4) (5) . Conversion of T4 to T3 also occurs in pituitaries of euthyroid rats (4) (5) (6) (7) . Tracer studies in these animals have suggested that the contribution of intrapituitary T4 5'-monodeiodination to pituitary nuclear T3 is equal to the quantity of nuclear T3 derived directly from the serum (6) . As a result, we estimated that the anterior pituitary nuclear T3 receptors were -80% saturated due to this additional source of T3 whereas nuclear receptors in liver and kidney, where this reaction contributes less to nuclear T,, were only 50% saturated. If this is the case, it has important physiological implications regarding the feedback regulation of thyrotropin (TSH) secretion by thyroid hormones. It also raises the possibility that individual tissues might have the capacity to regulate the local intracellular T3 concentration instead of depending entirely on the circulation for this hormone.
Comparison of the radioimmunoassayable nuclear T3 in single anterior pituitaries with that expected from the serum T3 in the same rats has not been reported. If our previous studies using tracer T3 and T4 are ' Abbreviations used in this paper: BSA, bovine serum albumin; GAB, glycine acetate buffer; RIA, radioimmunoassay; ti, equilibrium time; TSH, thyroid-stimulating hormone; T4, L-thyroxine; T3, 3,5,3' L-triiodothyronine.
valid, substantially greater quantities of radioimmunoassayable nuclear T3 should be present in the anterior pituitary than can be accouinted for by the concentration of serum T3 and the nuclear:serum T3 ratio. Ouir earlier attempts at these analyses were hampered by the presence of "T3-like" material that eltuted from the resin used to extract T3 from the pituitary nuiclei (8) .
This background material was present in sufficiently high quantities that the estimated pituitary nuclear T3 concentrations in normal rats were highly variable. Using the present methodology, this problem has been eliminated and reproducible restults have been obtained. The tubes were then incubated for 40 mill in ani ice-water bath after which they were centrifuiged at 2,000 g for 15 min and the supernate decanted and counted. The charcoal soltution was a 1:64 diluition in GAB of a suspensioni containing 1.2 g dextran and 12.5 g decolorizing norit charcoal per liter GAB. Sufficient cotints were collected to achieve >95% coUnltinlg accuracy. The [1251] T3 present in the nuclei did not contribute significantly to the couints added for the RIA.
METHODS
In Fig. 1 is shown a typical displacement curve for T. Specifically bound T3 ranged from 22 to 30%. The minimuin dletectable T3 concenitration as (lefined by that dose resulting in ['251]T3 displacemienit from antibody greater than two standard deviations fromii the "zero" binding varied frollm 0.6 to 2.5 pg T3/tube. In most assays, it was 1.25 pg. The quantity of T3 that caused a 50% decrease fromi zero binding was Fig. 1 is the displacemient of t'251]T3 from antibody by increasing aliquots of pituitary nuclear extract. For this experimnent, the nuclear extract from six anterior pituitaries of euthyroid rats were pooled and redissolved in onehalf the customary buffer volume. In Fig. 1 , 100 tl corresponds roughly to the quantity of nuclear extract custonmarily present per tube. As shown, the displacemnent caused by increasing quantities of niuclear extract is parallel to the displacement curve for authentic T3. Nonspecifically bound T3 in the standard tubes varied from 7 to 11%. As previously discuissed, a variable portion (one-third to one-half) of this "nonspecifically" bound label is 1251 which does not bind to charcoal (12 The quantity of T3 per tube in the assay depended upon the thyroid status of the rat and on the recovery of nuclear T3 throughout the isolation procedure. The major losses occuirred in the isolation of the nuclei (10-15%) and in the ethanol extraction of T3 from nuclei (20%). Therefore, because the total pituitary nuclear extract was divided into 3.2 aliquots, roughly 21% of the pituitary nuclear T3 was assayed in each tube. For normnal rats and hypothyroid rats injected with T3 (see below), this resulted in roughly 5-6 pg of T3 per tube. In hypothyroid rats not given T3, <1-2 pg of T3 were present per tube.
Anterior pituitary niuclear T3 in chronically htypothyroid rats with and w,ithout injected T3. In Table  I , part A, are shown anterior pituitary nuclear T3 measurements in seven hypothyroid rats. The serum T3 in these rats was 16±+3.6 ng/dl and serum T4 was <0.25 ug/dl confirmning the hypothyroid state. This was further verified by measurements of TSH that were >1,000 .tU/ml wvith a nornmal range for our assay of 50-250 AU/ml. Rats prepared in this fashion also have extremely low hepatic mitochondrial a-glycerophosphate dehydrogenase activities in addition to cessation of weiglht gain and are then physiologically hypothyroid in spite of clearly detectable seru-m T3 concentrations (17, 18) . The nuclear T3 by RIA in these rats was 9.1 pg/pituitary or 0.18 pg/ug DNA. In the last two columns of Since the quantities of nuclear T3 measured in the hypothyroid animals given T3 and in the normal animals were quite similar, and because the nuclear: serum ratio for tracer T3 in the hypothyroid animals was also known, we compared the calculated nuclear: serum T3 ratios for tracer T3 with those of radioimmunoassayable T3 in both experiments. The serum T3 concentrations in the hypothyroid rats were the sum of the injected T3 determined from the serum counts and the specific activity and the preinjection radioimmunoassayable T3. These data are summarized in Table II . In the 10 hypothyroid rats given 400 ng T3/100 g body wt, the nuclear:serum ratio for tracer T3 was 0.14±0.1, whereas that for radioimmunoassayable T3was 0.18+0.1. These values were not significantly different. In the 29 normal rats, the nuclear:serum ratio for tracer T3 was 0.42+0.02, whereas that for radioimmunoassayable T3 was 1.2+0.08. The difference between these two ratios was highly significant (P < 0.001). The fraction of nuclear T3 derived from derives from intrapituitary T4 to T3 conversion.
DISCUSSION
Methodology. The data in Fig. 1 and in Table I , indicate that the recovery of T3 froml pituitary nuclei is adequlate and that the material extracted from the nuclei gives a parallel displacemiient curve to that obtained with authentic T3. However, it appears from Table I , part B, that the recovery of known quantities of T3 from the nucelei is -17% (or 5 pg) above that expected based on specific activity calctulations. A similar discrepancy of 6 pg was observed in pituitary nuclei froin hypothyroid rats though this might be attributed in pairt to the small quantities of T3 being assaved. Control studies have shown that there is no T3-like material either in the ethaniol or in the solutions used to isolate nuclei or reconstituite the dried nuclear extracts. There remain several possible explanations for the discrepancy. One is that somne pituitary nuclear T3 could be attribluted to the presence of quantities of T4 in the serum that are below the limit of detectability using the T4 assay described (0.25 ,Ag/dl). A rough estimate of this potential contribution can be made as follows. We have previously reported that in euthyroid rats, the nuclear T3 derived from serumn T4 via intrapituiitary conversioni is 1.3 ±0.2 x 10-2 x ng T4/ml seruLm per mg DNA (6) . In a euthyroid rat with a plasma T4 of40 ng/ml, this source would contribute 0.52 ng T3/mg DNA (or pg T3/tLg DNA). T4 5'-monodeiodination is approximately threefold more active in vitro in anterior pituitary fragments from hypothyroid rats than in those from euthyroid animals (4) . This difference is supported by comnparison of the ratios of pituitary ntuclear ['25I]T3 to serumi [1211] T4 determined in vivo which are also higher in hypothyroid rats (2, 6) . Therefore, a sertum T4 of 2 ng/ml in a hypothyroid rat could result in 1. A second consideration is in the acculracy of the determination of the nuclear per serum T3 ratio and consequently the expected nuclear T3. It has been previously determined that the only point at which the specific activity of T3 in the serum is the same as that of the portion of the intracelluilar T3 pool derived from serum is at the time of peak nuclear occupancy (the "equilibrium time point" or tin) (20) (21) (22) . We have shown that there does not appear to be a demonstrable tm for pituitary nuclear T3 but rather a period of maximum nuclear T3 that may last from 30 to 120 min after T3 injection (1, 6) . During this time, the tracer T3 in the serum is decreasing. Becauise the nuclear T3 remains constant as seru-m T3 falls, the nuclear:serum ratio is rising over the tm. The difference in the nuclear:serum ration between 30 min and 2 h can be as much as 50% (6). Because we presume there is an actual tm but recognize that this m-oment is impossible to detect given the limits of the experimental methods, we have chosen a time of 60 min for these studies which both we and Oppenheimer et al. (19) have estimated to be the best approximation of the midpoint of the tm for the euthyroid pituitary (6) . An underestimate of the nuclear: serum ratio couild explain a relatively small portion of the above discrepancy because the increment of 50% in expected nuclear T3 would apply only to that quantity of nuclear T3 derived from the endogenous T3 present in the serunm. Lastly, it is possible that there are crossreacting T3-like substances in the nuclear extract. This possibility cannot be rigorouisly excluded on the basis of the present information.
Despite the above, the present method would appear to have satisfactory accuracy for the purposes of the present study, especially in light of the 18-pg T3/pituitary discrepancy between observed and expected nuclear T3 in anterior pituitary nuclei from euthyroid rats. This large difference can be attributed to the T3 derived from intrapittuitary T4-5'-monodeiodination and therefore confirms our earlier tracer studies (6) .
The discrepancy of 0.40 pg T3/,.g DNA is quite similar to the predicted contribuition of seru-m T4 to anterior pituiitarv nuclear T3 (0.52 pg T3/,ug DNA) as calculated above for rats with a serum T3 of 40 ng/ml based on our previouis report (6) . The estimation of the quantity of nuclear T3 derived from intrapituitary T4-5'-monodeiodin4tion depends on both the RIA of total nuclear T3 and the estimate of the contribution of serum T3
to nuclear T3 via the nuclear:serum T3 ratio. The limitations of the latter with respect to the pituitary have been diseussed above. Even if the appropriate nuclear: serum T3 ratio were as much as 50% higher, the measured nuclear T3 of 28 pg would still be substantially more than the 14 pg which could then be attributed to serum T3. However, the estimate of the fraction of the nuclear T3 derived from T4 in this case would decrease from 65 to 50%. Another way of evaluating these results is presented in Table II . The similarity of the tracer and lIA nuclear:serum T3 ratios in the T3-injected hypothyroid rats is in marked contrast to the discrepancy between these two nuclear:serum T3 ratios in the normal rats where serum T4 is present.
Comparison ofthese results with previous studies. We are not aware of previous RIA measurements of pituitary nuclear T3, but two reports of total pituitary T3 measurements have been published. Gordon (24) . They found a total pituitary T3 of 70+4 (SE) pg per anterior pituitary gland. Because it is likely that these female rats were smnaller than the males used in this study, the value calculated for total pituitary T3 would appear to be in good agreement with that ofthese authors, though somewhat higher than that of Gordon and Spira. Physiological implications. We have previously shown that in both hypothyroid and euthyroid rats, the apparent contribution of intracellular T4 to T3 conversion to nuclear T3 was much greater in the pituitary gland than it was in the liver, kidney, or heart (2, 6) . The results suggested that this source of nuclear T3 might be quantitatively significant in pituitary and less so in other tissues. The substantial excess of radioimmunoassayable pituitary nuclear T3 over that predicted from serum T3 measuremnents is in marked contrast to the general agreement between these two methods for estimating T3 in liver and kidney nuclei reported by Surks and Oppenheimer (25) . An important consequence of the intrapituitary T3 derived from T4 is that it results in a greater saturation of the nuclear T3 receptors in this tissue than can be obtained from serum T3 alone at its endogenous concentration. The 0.63-pg T3/,Ug DNA in the present studies would result in 82% saturation of anterior pituitary nuclear receptors which is quite similar to our previous estimnate of 78% saturation based on pulseinjection tracer methodology (6) . The latter studies also suggested that < 10% ofpituitary nuclear iodothyronine is T4. If the anterior pituitary nuclear iodothyronine receptor does bear a casual, inverse relationship to TS H production as has been suggested fromn our data (1, 2) and fromn studies of pituitary thyrotrophs in culture (26) , and if the nuclear receptor saturation in thyrotrophs is simnilar to the average pituitary value of 82%, then TSH secretion could increase and remain increased xlhen serumn T4 is reduced even if serum T3 remains or returns to normal. This would have an important role in the compensatory response of the thyrotroph to early hypothyroidism or iodine deficiency. It differs importantly froin the situation in most other tissuies of the rat that would appear to depend largely if not entirely on serumiii T3 alone for nuiclear T3. A high degree of endogenous nuclear T3 receptor saturation in the somatotrophs of euthyroid rats might also explain the failure of growth hormone secretion to increase after thyroid hormone administration as reported by Couloumbe et al. (27) . The physiological explanation for the unique importance of local T4-5'-monodeiodination as a source of intracellular T3 in this critically important endocrine tissuie is not understood at the present timne.
